debrisoquin and 2-hydroxydesipramine

debrisoquin has been researched along with 2-hydroxydesipramine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brøsen, K; Gram, LF; Kragh-Sørensen, P1
Bech, P; Bertilsson, L; Brøsen, K; Gram, LF; Klysner, R; Otton, SV1
Birgersson, C; Ericsson, O; Mellström, B; Sjöqvist, F; Spina, E; Steiner, E; von Bahr, C1
Alm, C; Dahl, ML; Ingelman-Sundberg, M; Iselius, L; Johansson, I; Lee, D; Sjöqvist, F; Svensson, JO1
Avenoso, A; Campo, GM; Caputi, AP; Perucca, E; Spina, E1

Trials

2 trial(s) available for debrisoquin and 2-hydroxydesipramine

ArticleYear
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism.
    European journal of clinical pharmacology, 1986, Volume: 30, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Debrisoquin; Depression; Desipramine; Female; Humans; Hydroxylation; Imipramine; Isoquinolines; Kinetics; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sparteine

1986
Phenobarbital induces the 2-hydroxylation of desipramine.
    Therapeutic drug monitoring, 1996, Volume: 18, Issue:1

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Desipramine; Enzyme Induction; Epilepsy; Half-Life; Humans; Hydroxylation; Male; Mixed Function Oxygenases; Phenobarbital; Phenotype; Polymorphism, Genetic

1996

Other Studies

3 other study(ies) available for debrisoquin and 2-hydroxydesipramine

ArticleYear
Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine, and mephenytoin.
    Therapeutic drug monitoring, 1991, Volume: 13, Issue:2

    Topics: Administration, Oral; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Chromatography, Thin Layer; Debrisoquin; Desipramine; Drug Interactions; Humans; Imipramine; Male; Mephenytoin; Phenotype; Quinidine; Sparteine

1991
Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:5

    Topics: Adult; Chromatography, High Pressure Liquid; Debrisoquin; Desipramine; Female; Humans; Hydroxylation; Isoquinolines; Kinetics; Male; Microsomes, Liver; Middle Aged; Phenotype

1984
Polymorphic 2-hydroxylation of desipramine. A population and family study.
    European journal of clinical pharmacology, 1993, Volume: 44, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Child; Debrisoquin; Desipramine; Female; Genetic Linkage; Genotype; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sweden

1993